Growth Support for Investor-Backed Companies

The plan says grow. The board or the investor wants to know why it hasn't yet, and “we're working on it” isn't an answer that holds up in a board meeting. This is about getting evidence behind that answer, not another slide of initiatives.

Investor-backed companies typically need a senior, outside read on the gap between the growth plan and current performance, evidence-based, not another round of initiatives, that the operating team can bring directly into a board or investor update.

Chart contrasting the growth plan with actual performance; the gap between them is the question the board is asking, and the work is an evidence-based answer to why

What this usually looks like

Growth targets were set at the deal, and the operating team is now living with the gap between the plan and the current run rate. Reporting exists, but it's built to describe activity, not to explain why performance is up or down against plan. Leadership needs a senior, outside perspective on where the constraint actually is before the next board update.

How we help

Growth Advisory provides senior, outside judgment on where growth is actually breaking down and what deserves the next dollar or hire, with a clear point of view the operating team can bring into the boardroom. Where the company is between leaders or in the middle of a reset, Interim CMO / Growth Leadership provides time-boxed executive stability.

Frequently asked questions

Do you work directly with the investor or board, or with the operating team?

With the operating team. The output is a clearer, evidence-backed answer the team can bring into board conversations, not a separate relationship with the investor.

Is this specific to private equity?

No. It applies to any company operating against an investor-set growth plan, PE-backed, venture-backed, or otherwise.

What does the board-ready output actually look like?

A named constraint with the evidence behind it: where growth is breaking down, why, what has been ruled out, and where the next dollar or hire should go. It is a diagnosis the operating team presents as their own, not a consultant deck presented alongside them.

How quickly can we have an evidence-based answer?

The first structured read typically comes together within the first several weeks, in time to shape the next board conversation. Depth follows: the early answer names the most likely constraint, and continued work either confirms it or sharpens it.

What should a board ask when growth misses plan?

Three questions expose most misses: where specifically in the revenue journey did performance fall short of the model, what evidence connects the current spend to the pipeline it was supposed to produce, and who owns the answer. If management cannot answer at that level of specificity, the problem is usually visibility and accountability before it is strategy.

Schedule a Discovery Call